This inventor holds 3 USPTO granted patents. Top assignee: Gentest Corporation. Active years: 2000-2002.
Company Filing History:
Years Active: 2000-2002
Title: **Vaughn P Miller: Innovator in Cytochrome P450 Research**
Introduction
Vaughn P Miller, an accomplished inventor based in Arlington, MA, has made significant contributions to the field of biochemistry through his innovative work on cytochrome P450 enzymes. With a total of three patents to his name, Miller's inventions are pivotal in understanding and assessing enzyme activity, which has substantial implications in drug development and safety.
Latest Patents
Miller's latest patents focus on enhancing the evaluation of cytochrome P450 enzyme activity. His first patent details the "Use of fluorescein aryl ethers in high throughput cytochrome P450 inhibition assays." This invention introduces novel fluorescent substrates designed specifically for human cytochrome P450 enzymes, along with methods for their manufacture and application. These substrates are essential for assessing enzyme activity and for identifying potential adverse drug interactions that can arise from inhibiting cytochrome P450 enzymes.
Another notable patent is the "Coumarin-based CYP3A fluorescent assay reagents," which also features innovative fluorescent substrates for cytochrome P450 enzymes. Similar to his previous work, this patent provides methods for their manufacture and use, further aiding in the assessment of cytochrome P450 CYP3A enzyme activity and the selection of compounds with inhibitory effects.
Career Highlights
Miller is currently employed at Gentest Corporation, where he continues to innovate within the realm of enzymatic assays. His passion for research and development has positioned him at the forefront of cytochrome P450 studies, contributing significantly to advancements in the pharmacokinetics of drugs.
Collaborations
Throughout his career, Miller has collaborated with esteemed colleagues, including Charles L Crespi and David Streser. These partnerships have fostered an environment of creativity and innovation, allowing for the development of highly specialized assay reagents that are critical to the pharmaceutical industry.
Conclusion
Vaughn P Miller stands out as a prominent inventor whose work on cytochrome P450 enzymes is reshaping the landscape of drug interaction assessments. His advancements in fluorescent substrates and assays not only enhance scientific understanding but also play a critical role in ensuring drug safety and efficacy. As a key figure at Gentest Corporation, Miller’s contributions promise to influence future innovations in biochemistry and pharmacology.